Journal of the Chinese Medical Association
Volume 71, Issue 3 , Pages 123-127, March 2008

An Investigation of the Differential Expression of Her2/neu Gene Expression in Normal Oral Mucosa, Epithelial Dysplasia, and Oral Squamous Cell Carcinoma in Taiwan

  • Yao Fong

      Affiliations

    • Department of Surgery, Chi-Mei Medical Center, Tainan, Taipei, Taiwan, R.O.C.
    • ,
  • Shan-Ju Chou

      Affiliations

    • Oral and Maxillofacial Surgery, Department of Dentistry, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • School of Dentistry, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    • ,
  • Kai-Feng Hung

      Affiliations

    • Department of Dentistry, Buddhist Tzu Chi General Hospital, Sindian, Taiwan, R.O.C.
    • ,
  • Ho-Tai Wu

      Affiliations

    • Oral and Maxillofacial Surgery, Department of Dentistry, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • School of Dentistry, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    • ,
  • Shou-Yen Kao

      Affiliations

    • Oral and Maxillofacial Surgery, Department of Dentistry, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • School of Dentistry, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Dr Shou-Yen Kao, Oral and Maxillofacial Surgery, Department of Dentistry, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.

Received 19 October 2007; accepted 25 January 2008.

Article Outline

Background

Her2/neu was thought to be a proto-oncogene with sequence homology to epidermal growth factor receptor (EGFR). Its overexpression was seen in many cancers and referred to regimens of anticancer therapy. The aim of this study was to investigate whether the abnormal expression existed in oral carcinogenesis.

Methods

Immunohistochemistry (IHC) was used to detect Her2/neu expression in normal oral mucosa (NOM) (n = 20), oral precancerous lesions of epithelial dysplasia (ED) (n = 20), and oral squamous cell carcinoma (OSCC) (n = 30). The association of clinicopathologic covariates of areca use, tumor size, neck lymph node metastasis, differentiation and stages of cancer with the expression of Her2/neu was examined. The significance of Neu immunoreactivity in different groups or with different covariates was investigated using Fisher's exact test.

Results

Her2/neu immunoreactivity was very low with Her2/neu(+) in 10% (2/20) of NOM cases and in 25% (5/20) of ED cases, respectively. The Her2/neu expression was high in OSCC cases, with 40% (12/30) of Her2/neu(+) and 10% (3/30) of Her2/neu(++). Significant difference was observed between NOM/ED and OSCC cases (p < 0.05). All clinicopathologic covariates showed no significant relation to the expression of Her2/neu in OSCC cases.

Conclusion

These findings suggested a dynamic change in Her2/neu expression during the development of OSCC. The overexpression of Her2/neu can be used as a marker in distinguishing NOM/ED from OSCC.

Key Words:  areca , differential expression , Her2/neu , oral cancer

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Lo WL , Kao SY , Chi LY , Wong YK , Chang RC . Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival . J Oral Maxillofac Surg . 2003;61:751–758
  2. Hung KF , Lin SC , Liu CJ , Chang CS , Chang KW , Kao SY . The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis . J Oral Pathol Med . 2003;32:461–467
  3. Chang KW, Kao SY, Tzeng RJ, Liu CJ, Cheng AJ, Yang SC, et al  Multiple molecular alterations of FHIT in betel-associated oral carcinoma . J Pathol . 2002;196:300–306
  4. Kao SY, We CH, Lin SC, Yap SK, Chang CS, Wong YK, et al  Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precan-cer lesions associated with smoking/betel use . J Oral Pathol Med . 2002;31:505–511
  5. Kao SY , Tu HF , Yang CC , Chang KW , Chang CS , Lin SC . The retinoic acid receptor-β (RAR-β) mRNA expression in the oral squamous cell carcinoma associated with betel quid use . J Oral Pathol Med . 2002;31:220–226
  6. Hung KF , Chang CS , Liu CJ , Lui MT , Cheng CY , Kao SY . Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma . J Oral Pathol Med . 2006;35:589–594
  7. Shintani S , Nakahara Y , Li C , Mihara M , Nakashiro KI . HER2/neu expression in oral squamous cell carcinoma . Asian J Oral Maxillofac Surg . 2004;16:172–176
  8. Popescu NC , King CR , Kraus NH . Localization of the erB-2 gene on normal and rearranged chromosomes 17 to bands of q12-21.32 . Genomics . 1989;4:362–366
  9. Akiyama T , Sudo C , Ogawara H , Toyoshima K , Yamamoto T . The product of human c-erB-2 gene: a 185-kDa glycoprotein with tyrosine kinase activity . Science . 1986;232:1644–1646
  10. Yamamoto T , Ikawa S , Akiyama T . Similarity of protein encoded by the human c-erB-2 gene to epidermal growth factor receptor . Nature . 1986;319:230–234
  11. Press MF , Cordon-Card C , Slamon DJ . Expression of the Her2/neu proto-oncogene in normal human adult and fetal tissues . Oncogene . 1990;5:953–962
  12. Tommasi S, Giannella C, Paradiso A, Barletta A, Mangia A, Simone G, et al  HER-2/neu gene in primary and local metastatic axillary lymph nodes in human breast tumors . Int J Biol Markers . 1992;7:107–113
  13. Roetger A , Merschjann A , Dittmar T , Jackisch C , Barnekow A , Brandt B . Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model . Am J Pathol . 1998;153:1797–1806
  14. Tiwari RK , Borgen PI , Wong GY , Cordon-Cardo C , Osborne MP . HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis . Anticancer Res . 1992;12:419–425
  15. Ross JS , Fletcher JA . The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy . Semin Cancer Biol . 1999;9:125–138
  16. Ciardiello F , Tortora G . A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor . Clin Cancer Res . 2001;7:2958–2970
  17. Cobleigh MA , Vogel CL , Tripathy D . Multinational study of the humanized anti-HER2 monoclonal antibody in women who have HER2 overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease . J Clin Oncol . 1999;17:2639–2648
  18. Venter DJ , Tuzi NL , Kumar S , Gullick WJ . Overexpression of the c-erB-2 oncogene protein in human breast carcinomas; immunohistochemical assessment correlates with gene amplification . Lancet . 1987;11:69–72
  19. Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, et al  Strong correlation between c-erB-2 over expression and overall survival of patients with oral squamous cell carcinoma . Clin Cancer Res . 1997;3:3–9
  20. Xia W, Lau YK, Zhang HZ, Xiao FY, Johnston DA, Liu AR, et al  Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members . Clin Cancer Res . 1999;5:4164–4174
  21. Kearsley JH , Leonard JH , Walsh MD , Wright GR . A comparison of epidermal growth factor receptor (EGFR) and c-erB-2 oncogene expression in head and neck squamous cell carcinomas . Pathology . 1991;23:189–194
  22. Craven JM , Pavelic ZP , Stambrook PJ , Pavelic L , Gapany M , Kelley DJ . Expression of c-erbB-2 gene in human head and neck carcinoma . Anticancer Res . 1992;12:2273–2276
  23. Field JK , Spandidos DA , Yiagnisis M , Gosney JR , Papadimitriou K , Stell PM . C-erB2 expression in squamous cell carcinoma of the head and neck . Anticancer Res . 1992;12:613–620
  24. Hou L , Shi D , Tu SM , Zhang HZ , Hung MC , Ling D . Oral cancer progression and c-erB-2/neu proto-oncogene expression . Cancer Lett . 1992;65:215–220
  25. Werkmeister R , Brandt B , Joos U . Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas . Oral Oncol . 2000;32:100–105

PII: S1726-4901(08)70003-0

doi:10.1016/S1726-4901(08)70003-0

Journal of the Chinese Medical Association
Volume 71, Issue 3 , Pages 123-127, March 2008

Article Tools